Urology billing mixes office-based diagnostic procedures (cystoscopy, bladder scans, biopsies) with a steady stream of E/M visits for chronic conditions, and payers pay close attention to whether each diagnostic procedure was medically necessary rather than routine screening.
Why This Specialty Is Billing-Complex
Many urology procedures can be bundled with an office visit on the same day, and NCCI edits govern exactly which combinations require a modifier to unbundle. PSA testing and prostate biopsies in particular carry payer-specific frequency and medical-necessity rules that differ for screening versus diagnostic intent.
Common CPT, ICD-10 & HCPCS Codes
- CPT 52000 — cystourethroscopy
- CPT 51798 — post-void residual urine measurement
- CPT 55700 — prostate biopsy
- CPT 51720 — bladder instillation of medication
- ICD-10 N40.x — benign prostatic hyperplasia
- ICD-10 N39.0 — urinary tract infection
- ICD-10 C61 — malignant neoplasm of prostate
Documentation Standards
The note should distinguish a screening PSA (routine, asymptomatic patient) from a diagnostic PSA (ordered to evaluate a specific symptom or abnormal prior finding), since the two are billed and covered differently. Cystoscopy and biopsy notes need the specific clinical indication documented, not just the underlying chronic diagnosis, to support medical necessity if the payer requests records.
Common Denial Reasons & How to Prevent Them
- Medical necessity denials when a diagnostic procedure is billed with only a screening-type diagnosis code
- Bundling denials when an office visit and a same-day scope procedure are billed without the correct modifier
- Frequency-limit denials on repeat PSA testing without documented clinical justification
- Denials for bladder instillation or catheter-related codes missing supply documentation
The 2026 Prostate Biopsy Code Overhaul
A significant coding change took effect January 1, 2026: CPT 55700, the old catch-all “biopsy, prostate; needle or punch, any approach” code, was deleted and replaced with a new nine-code family (55705-55715) that differentiates by approach and imaging guidance — transrectal versus transperineal, ultrasound-guided versus MRI-fusion targeted versus in-bore CT/MRI-guided, systematic versus targeted, plus an add-on code for each additional targeted lesion beyond the first. Practices still billing the old 55700 code will see denials. One important related change: imaging-guidance codes that used to be billed separately alongside the old code are now bundled into every code in the new family — don’t unbundle transrectal ultrasound guidance as a separate line item. Given how new this code family is, verify exact code selection against the current-year CPT manual for the specific approach and imaging modality actually documented, rather than relying on a secondary summary.
Bundling and Modifier Pitfalls
Diagnostic cystourethroscopy (52000) is designated a “separate procedure” and is not separately billable whenever a therapeutic cystoscopic procedure — biopsy (52204), minor lesion treatment (52224), or transurethral resection of bladder tumor (52234/52235/52240, tiered strictly by the largest tumor size documented in centimeters, not by pathology) — is performed in the same session. Billing 52000 alongside a therapeutic code in the same encounter is one of the most common urology bundling denials. As in other office-procedure-heavy specialties, modifier 25 is required when a genuinely separate, significant E/M service is billed on the same day as an in-office procedure like cystoscopy, and the note needs to document that separate work explicitly rather than just the decision to perform the procedure itself.
PSA Testing and Catheter Frequency Limits
PSA testing has a screening-versus-diagnostic distinction that drives both code and diagnosis selection: HCPCS G0103 is the screening PSA code, covered by Medicare once every 12 months (with at least 11 months elapsed since the prior covered screening) for men age 50 and up, billed with a screening diagnosis rather than a symptom code. CPT 84153 is the diagnostic PSA code, used when signs, symptoms, or a suspected or known prostate condition justify the test, billed against the relevant symptom or disease diagnosis rather than a screening code. A common denial driver is a mismatch between the code billed and the diagnosis attached — billing the diagnostic code against what was actually an asymptomatic screening encounter, or the reverse.
Catheter-related supplies also carry specific Medicare frequency limits worth knowing: indwelling catheters are covered for routine replacement once per month, with more frequent changes requiring documented medical necessity such as accidental removal, malfunction, blockage, or a history of recurrent UTIs. Per CMS’s own compliance review of urological-supply claims, the large majority of claim errors in this category stem not from medical necessity or coding mistakes but from missing or insufficient documentation — a strong reminder that the frequency limit itself is rarely the real problem; the missing paper trail justifying an exception to it is.
Tools That Help
ICD-10-CM Search · Denial Code Lookup · Modifier/POS Reference · RCM Calculators · NPI Lookup